Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 12.767% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a CC(C)n1nnnc1SCC(=O)c1ccc2c(c1)OCCO2
b CC1CCN(S(=O)(=O)c2ccc3c(c2)N(CC(=O)NCCCOC(C)C)C(=O)CO3)CC1
Answer: b. CC1CCN(S(=O)(=O)c2ccc3c(c2)N(CC(=O)NCCCOC(C)C)C(=O)CO3)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCN(S(=O)(=O)c2ccc3c(c2)N(CC(=O)NCCCOC(C)C)C(=O)CO3)CC1
CC1CCN(S(=O)(=O)c2ccc3c(c2)N(CC(=O)NCCCOC(C)C)C(=O)CO3)CC1
2-[6-(4-methylpiperidin-1-yl)sulfonyl-3-oxo-1,4-benzoxazin-4-yl]-N-(3-propan-2-yloxypropyl)acetamide